Showing 672 news articles about New & experimental HIV treatments

Filters Content type: Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

Pharmaceutical industry

High-End HIV Drug Stribild To Set Gilead Sciences Apart

Editor's pick
Seeking Alpha
6 September 2012
HIV treatment for children & young people

World's first HIV/AIDS nanomedicines

Editor's pick
Hospital Pharmacy Europe
3 September 2012
Pharmaceutical industry

Quad approved in US: exorbitant cost likely to block use in Europe

Editor's pick
HIV i-Base
28 August 2012
New & experimental HIV treatments

F.D.A. Approves Once-a-Day Pill for H.I.V.

Editor's pick
New York Times
28 August 2012
The search for an HIV prevention vaccine

Drug improves vaccine response in HIV patients

Editor's pick
Imperial College London press release.
24 August 2012
Pharmaceutical industry

AIDS pill's price tag draws criticism

Editor's pick
San Francisco Chronicle
24 August 2012
Neurological & cognitive problems

Hope for patients with HIV-associated cognitive impairment

Editor's pick
EurekAlert
15 August 2012
New & experimental HIV treatments

Bionor Pharma Rises as HIV Drug Study Gets Approval

Editor's pick
Bloomberg BusinessWeek
14 August 2012
New & experimental HIV treatments

Potential anti-CXCR4 drug molecule shows enhanced anti-HIV activity

Editor's pick
Science Codex
10 August 2012
Adherence

Digital pills make their way to market

Editor's pick
Nature
2 August 2012
New & experimental HIV treatments

Pioneering study shows drug can purge dormant HIV

Editor's pick
Science Daily
25 July 2012
Vaginal rings & topical PrEP

Researchers to test monthly vaginal ring for HIV prevention

Editor's pick
Reuters
25 July 2012
New & experimental HIV treatments

Similar Efficacy, Side Effects in Study of Gilead Booster Cobicistat and Norvir

Editor's pick
AIDSMeds
25 July 2012
New & experimental HIV treatments

Merck Signs Two Deals for Novel HIV Drug Candidates and Initiates Phase II Clinical Trial of MK-1439 for HIV

Editor's pick
Merck press release
24 July 2012
New & experimental HIV treatments

TAG/i-base 2012 Pipeline Report - HIV/HCV/TB

Editor's pick
Treatment Action Group
21 July 2012
New & experimental HIV treatments

HIV drug reduces graft-vs.-host disease in bone marrow transplant patients

Editor's pick
Google Alerts HIV
12 July 2012
New & experimental HIV treatments

Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV

Editor's pick
Market Watch (press release)
11 July 2012
New & experimental HIV treatments

HIV quad pill 'may improve care'

Editor's pick
BBB News
29 June 2012
New & experimental HIV treatments

Gilead Sciences files for approval of cobicistat

Editor's pick
Bloomberg BusinessWeek
29 June 2012
Weight gain & lipodystrophy

Theratechnologies sinks on HIV drug setback

Editor's pick
Reuters
22 June 2012
New & experimental HIV treatments

European Medicines Agency Validates Gilead ’s Marketing Application for Elvitegravir for Treatment of HIV Infection

Editor's pick
Gilead press release
19 June 2012
New & experimental HIV treatments

New Drug-Screening Method Yields Long-Sought Anti-HIV Compounds

Editor's pick
Scripps Research Institute
15 June 2012
New & experimental HIV treatments

UBC drug formulation receives $1.1 million for clinical development as HIV treatment

Editor's pick
EurekAlert (press release)
6 June 2012
New & experimental HIV treatments

Gilead Files European Marketing Application for Boosting Agent Cobicistat

Editor's pick
Gilead press release
25 May 2012